India’s Patent Act On Trial

18 Feb 2007
View Resource

In May 2006, Novartis challenged India’s standard for patentability of an invention as being unconstitutional and not in compliance with the WTO’s TRIPS Agreement. The outcome of the case is likely to have major implications for many developing countries.

Partner with us now to build
a more just and equitable
medicine system for all.